Agenda
CardioVascular Interventions Summit
Program Overview
Friday, February 16 – Saturday, February 17
CardioVascular Interventions Summit attendees can expect an engaging lineup of insightful lectures, hands-on live case demonstrations, and interactive panel discussions. These sessions are carefully curated to provide comprehensive updates on the management of cardiovascular diseases, review the latest evidence-based research, and delve into optimal techniques and technologies.
Friday, February 16, 2024 | CardioVascular Interventions Summit |
---|---|
7:00 – 8:00 am | Registration/Breakfast/Exhibits |
8:0o – 8:20 am | Welcome Neil Gheewala, MD, Thomas Waggoner, DO, Mimi Coomler and Linda Andrews |
8:20 – 10:15 am | Mitral Transcatheter Edge to Edge Repair Moderators: Saibal Kar, MD and Paul Mahoney, MDPanel:Marvin Eng, MD, Soundos Moulla, MD, Manny Reyes, MD, Poonam Velagapudi, MD, and Brian Whisenant, MD |
8:20 – 8:40 am | CVIS Pioneer: The Journey to Understanding the Mitral Valve Saibal Kar, MD |
8:40 – 8:50 am | Advances in MitraClip TEER: Complex Cases and G4 Registry Paul Mahoney,, MD |
8:50 – 9:00 am | Pascal TEER: The New Kid on the Block Brian Whisenant, MD |
9:00 – 9:15 am | CVIS Case Panel Controversy: TEER Device Selection Manny Reyes, MD |
9:15 – 9:45 am | Live Case: PASCAL Case Site: Tucson Medical CenterCase Operators: Thomas Waggoner, DO and Mark Bieniarz, MD |
9:45 – 10:15 am | Live Case: MitraClip Case Site:Tucson Medical CenterCase Operators: Neil Gheewala, MD and Hursh Naik, MD |
10:15 – 10:45 am | Break/Exhibits |
10:45 – 12:05 pm | Cardiogenic Shock/High-Risk PCI Moderators: William O’Neill, MD and Elizabeth Juneman, MDPanel:Amy Daliman, DO, Marvin Eng, MD, Amir Kaki, MD, Manny Reyes, MD, Oscar Rosales, MD, and Mark Bieniarz, MD |
10:45 – 11:05 am | CVIS Pioneer: The National Cardiogenic Shock Initiative in 2024 William O’Neill, MD |
11:05 -11:15 am | Identifying and Escalating Care in Cardiogenic Shock Elizabeth Juneman, MD |
11:15 -11:25 am | Hemodynamics in Cardiogenic Shock Amir Kaki, MD |
11:25 – 11:35 am | Role of Structural Heart Interventions in Shock Marvin Eng, MD |
11:35 – 11:45 am | The Cardiogenic Shock Toolbox Amir Kaki, MD |
11:45 – 11:55 am | Investigational Tools in HRPCI: Impella ECP Amir Kaki, MD |
11:55 am – 12:05 pm | CVIS Controversies: How Best to Support? Mark Bieniarz, MD |
12:05 – 1:25 pm | Lunch/Exhibits |
1:25 – 2:25 pm | Mitral Valve Replacement/Repair Moderators: Thomas Waggoner, DO and Brian WhisenantPanel: Johnathan Schwartz, MD, William O’Neill, Marvin Eng, MD, Raj Janardhan, MD Paul Mahoney, MD and Michael Reardon, MD |
1:25 -1:35 pm | Current State of TMVR Options Marvin Eng, MD |
1:35 -1:45 pm | Ongoing Clinical Trial Considerations Pradeep Yadav, MD |
1:45 – 1:55 pm | Surgery vs. TEER vs TMVR Trial in 2023 Michael Reardon, MD |
1:55 – 2:05 pm | Mitral Valve Imaging: Modalities and Case Planning Raj Janardhanan, MD |
2:05 – 2:15 pm | CVIS Case Panel Controversies: What’s this Patient’s Best Option Paul Mahoney, MD |
2:15 – 2:25 pm | Local Experience of TMVR Thomas Waggoner, DO |
2:25 – 2:45 pm | Break/Exhibits |
2:45 – 4:35 pm | Left Atrial Appendage Closure Moderators:Poonam Velagapudi, MD and Brian Whisenant, MDPanel: Neil Gheewala, MD, Poonam Velagapudi, MD, Soundos Moulla, MD, Timothy Byrne, DO, Paul Mahoney, MD, Saibal Kar, MD, and Johnathan Schwartz, MD |
2:45 – 3:05 pm | Is LAA Closure as Good as a NOAC in 2024? Soundos Moulla, MD |
3:05 – 3:15 pm | Watchman LAA Closure: The Old Guard Saibal Kar, MD |
3:15 – 3:25 pm | Amulet LAA Closure: Another New Kid in LAA Tim Byrne, DO |
3:25 – 3:35 pm | Optimization of LAA Closure Strategies Brian Whisenant, MD |
3:35 – 3:45 pm | Left Atrial Appendage Closure with 4D ICE Johnathan Schwartz, MD |
3:45 – 4:10 pm | Live Case: Watchman with 4D ICE Case Site: Tucson Medical CenterCase Operators: Thomas Waggoner, DO |
4:10 – 4:35 pm | Recorded Case: Amulet LAA Closure Case Site: St. Bernard’s Heart and VascularCase Operators: Devi Nair, MD |
4:35 – 6:30 pm | Welcome Reception/Exhibits |
Saturday, February 17, 2024 | CardioVascular Interventions Summit |
---|---|
7:00 – 8:00 am | Breakfast/Exhibits |
8:00 – 8:05 am | Welcome from ACC Arizona Chapter Mathew Hutchinson, MD, FACC, Incoming President-Elect |
8:05 – 8:20 am | Presentation of CVIS Lifetime Achievement Award Neil Gheewala, MD and Thomas Waggoner, DO |
8:20 am – 10:00 am | High-Risk PCI Moderators: William O’Neill, MD and Mark Bieniarz, MDPanel: Thomas Waggoner, DO, Michael Reardon, MD, Amy Daliman, DO, Oscar Rosales, MD, Poonam Velagupudi, MD and Manny Reyes, MD |
8:20 – 8:40 am | CVIS Pioneer: The Evolution of PCI and Hemodynamic Support William O’Neill, MD |
8:40 – 8:50 am | Medical Management vs High Risk PCI Prior to Structural Interventions Amy Daliman, DO |
8:50 – 9:00 am | Lesion Modification in 2024: Atherectomy, Lithotripsy, or Both? Poonam Velagupudi, MD |
9:00 – 9:10 am | Utilization of Hemodynamic Support in High-Risk PCI Mark Bieniarz, MD |
9:10 – 9:20 am | Role of Intracoronary Imaging for PCI Osar Rosales, MD |
9:20 – 10:00 am | Live Case: High-Risk PCI with Mechanical Circulatory Support Case Site: The Valley HospitalCase Operator: Rajiv Tayal, MD |
10:00 – 10:30 am | Break/Exhibits |
10:30 – 12:00 pm | Two Decades of TAVR Science Moderators: Raj Makkar, MD and Michael Reardon, MDPanel: Paul Mahoney, MD, Brian Whisenant, MD, Jonathan Schwartz, MD, Timothy Byrne, DO, and Pradeep Yadav, MD |
10:30 -10:50 am | CVIS Pioneer: TAVR two decades into the Science Brian Whisenant, MD |
10:50 – 11:00 am | TAVR in Low-Risk Patients Michael Reardon, MD |
11:00 – 11:10 am | Aortic Insufficiency: Emerging Technologies Pradeep Yadav, MD |
11:10 – 11:20 am | Bicuspid Aortic Valve Disease: When to hold ’em or fold’em Raj Makkar, MD |
11:20 – 11:30 am | Role of Cerebral Embolic Protection in TAVR Jonathan Schwartz, MD |
11:30 – 12:00 pm | Live Case: Edwards SAPIEN 3 RESILIA TAVR Case Site: Tucson Medical CenterCase Operators: Neil Gheewala, MD and Thomas Waggoner, DO |
12:00 – 1:15 pm | Lunch/Exhibits/Product Theater |
12:15 – 1:00 pm | Product Theater • Exhibit Hall with Lunch Service Title and PresenterRedefining the Treatment Landscape for Symptomatic NYHA Class II–III oHCM with the First and Only FDA-Approved Cardiac Myosin Inhibitor Richard Wright, MD Chairman, Pacific Heart institute, Santa Monica, CA The special session is supported through the sponsorship of Bristol Meyer Squibb. |
1:15 – 2:55 pm | Lifetime Management of Aortic Valve Disease Moderators: Neil Gheewala, MD and Pradeep Yadav, MDPanel:Hursh Naik, MD, William O’Neill, MD, Poonam Velagapudi, MD, Paul Mahoney, MD, and Michael Reardon, MD |
1:15 – 1:25 pm | The Arsenal of TAVR Valve Options Pradeep Yadav, MD |
1:25 – 1:35 pm | Lifetime Aortic Valve Management Choices: A Surgeon’s Perspective Michael Reardon, MD |
1:35 – 1:45 pm | Lifetime Aortic Valve Management Choices: A Cardiologist’s Perspective Hursh Naik, MD |
1:45 – 1:55 pm | TAVR in TAVR: Leaflet Modification and Therapeutic Options Paul Mahoney, MD |
1:55 – 2:05 pm | CVIS Case Controversies: Optimal Valve Selection Panel Poonam Velagapudi, MD |
2:05 – 2:30 pm | Live Case: CoreValve TAVR Case Site: Tucson Medical CenterCase Operators: Thomas Waggoner, DO |
2:30 – 2:55 pm | Live Case: Navitor TAVR Case Site: Los Robles Medical CenterCase Operators: Saibal Kar, MD and Greg Fontana, MD |
2:55 – 3:15 pm | Break/Exhibits |
3:15 – 4:25 pm | Tricuspid Valve Disease: The Forgotten Valve Moderators:Paul Sorajja, MD and Jonathan Schwartz, MDPanel:Nadira Hamid, MD, Brian Whisenant, MD, Paul Mahoney, MD, and Hursh Naik, MD |
3:15 – 3:35 pm | CVIS Pioneers: Emerging Patient Options for Tricuspid Valve Disease Paul Sorajja, MD |
3:35 – 3:45 pm | What is the Indication for Tricuspid Valve Intervention? Hursh Naik, MD |
3:45 – 3:55 pm | Tricuspid Valve Anatomy by TEE and CT Nadira Hamid, MD |
3:55 – 4:05 pm | Transcatheter Tricuspid Valve Repair: Results of the TRILUMINATE Trial Jonathan Schwartz, MD |
4:05 – 4:15 pm | Transcatheter Tricuspid Valve Replacement: TRISCEND II Brian Whisenant, MD |
4:15 pm | Closing Thoughts and Adjourn2025 |